Prediction of NAFLD occurrence in prediabetes patients

被引:18
作者
Vesa, Cosmin Mihai [1 ]
Behl, Tapan [2 ]
Nemeth, Sebestian [3 ]
Bratu, Ovidiu G. [4 ]
Diaconu, Camelia C. [5 ]
Moleriu, Radu Dumitru [6 ]
Negrut, Nicoleta [7 ]
Zaha, Dana C. [1 ]
Bustea, Cristiana [1 ]
Radu, Florentina Ionita [8 ]
Bungau, Simona [7 ]
机构
[1] Univ Oradea, Fac Med & Pharm, Dept Preclin Disciplines, Oradea 410073, Romania
[2] Chitkara Univ, Chitkara Coll Pharm, Rajpura 140401, Punjab, India
[3] Univ Oradea, Fac Med & Pharm, Dept Pharm, Oradea 410073, Romania
[4] Carol Davila Univ Med & Pharm, Clin Dept 3, 8 Eroii Sanit Blvd, Bucharest 050474, Romania
[5] Carol Davila Univ Med & Pharm, Dept 5, Bucharest 050474, Romania
[6] West Univ Timisoara, Fac Math & Comp Sci, Dept Math, Timisoara 300223, Romania
[7] Univ Oradea, Fac Med & Pharm, Dept Psychoneurosci & Recovery, Oradea 410073, Romania
[8] Emergency Univ Cent Mil Hosp, Dept Gastroenterol, 134 Calea Plevnei St, Bucharest 010825, Romania
关键词
NAFLD; prediabetes patients; metabolic syndrome; leptin; HbA1c; FATTY LIVER-DISEASE; INHIBITION; PREVALENCE; RISK;
D O I
10.3892/etm.2020.9320
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is a component of metabolic syndrome that significantly increases the cardiovascular risk of patients with glucose metabolism alterations. This study identified the prevalence of NAFLD, predictors of NAFLD and explored the link between insulin sensitivity, insulin resistance and leptinemia in 143 patients registered with prediabetes. Abdominal ultrasound was performed, and fasting insulin, postprandial insulin, leptin levels, common clinical/biochemical determinations were assessed. Certain variables that can predict NAFLD existence were determined and it was found that there is a high prevalence of NAFLD in patients with prediabetes. In univariate analysis, statistically significant associations (P<0.05) were found between waist circumference, systolic blood pressure, diastolic blood pressure, triglycerides, HDL-cholesterol, insulin sensitivity, <beta>-cell function, leptin and NAFLD presence. The coefficients for the variables which obtain statistically significant association (P<0.05) are low, except for leptin which is the biochemical parameter that (in both univariate and multivariate analysis) is a strong predictor of NAFLD presence.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Clinical characteristics of patients with non-alcoholic fatty liver disease (NAFLD) in Germany - First data from the German NAFLD-Registry
    Geier, Andreas
    Rau, Monika
    Pathil-Warth, Anita
    von der Ohe, Manfred
    Schattenberg, Joern
    Dikopoulos, Nektarios
    Stein, Kerstin
    Serfert, Yvonne
    Berg, Thomas
    Buggisch, Peter
    Demir, Muenevver
    Roeb, Elke
    Wiebner, Bianka
    Wedemeyer, Heiner
    Zeuzem, Stefan
    Hofmann, Wolf P.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (01): : 60 - 70
  • [32] Prognostic Value of the Magnesium Depletion Score for Mortality Outcomes Among NAFLD Patients
    Ding, Yue
    Xu, Wei
    Feng, Yuntao
    Shi, Baomin
    Wang, Wei
    INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH, 2025, 95 (02)
  • [33] Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD
    Ciardullo, S.
    Bianconi, E.
    Cannistraci, R.
    Parmeggiani, P.
    Marone, E. M.
    Perseghin, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (08) : 1547 - 1553
  • [34] Impact on Prevalence of the Application of NAFLD/MAFLD Criteria in Overweight and Normal Weight Patients
    Ordonez-Vazquez, Ana Luisa
    Juarez-Hernandez, Eva
    Zuarth-Vazquez, Julia Maria
    Ramos-Ostos, Martha Helena
    Uribe, Misael
    Castro-Narro, Graciela
    Lopez-Mendez, Ivan
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (19)
  • [35] The monocyte-to-high-density lipoprotein ratio is associated with the occurrence of atrial fibrillation among NAFLD patients: A propensity-matched analysis
    Wang, Leigang
    Zhang, Yao
    Yu, Bing
    Zhao, Jianqi
    Zhang, Wenjing
    Fan, Hongxuan
    Ren, Zhaoyu
    Liang, Bin
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [36] Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)
    Bischoff, Jenny
    Gu, Wenyi
    Schwarze-Zander, Carolynne
    Boesecke, Christoph
    Wasmuth, Jan-Christian
    van Bremen, Kathrin
    Dold, Leona
    Rockstroh, Jurgen K.
    Trebicka, Jonel
    ECLINICALMEDICINE, 2021, 40
  • [37] Should Patients With NAFLD/NASH Be Surveyed for HCC?
    Reig, Maria
    Gambato, Martina
    Man, Nancy Kwan
    Roberts, John P.
    Victor, David
    Orci, Lorenzo A.
    Toso, Christian
    TRANSPLANTATION, 2019, 103 (01) : 39 - 44
  • [38] Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults
    Kuehn, Tilman
    Nonnenmacher, Tobias
    Sookthai, Disorn
    Schuebel, Ruth
    Pacheco, Daniel Antonio Quintana
    von Stackelberg, Oyunbileg
    Graf, Mirja E.
    Johnson, Theron
    Schlett, Christopher L.
    Kirsten, Romy
    Ulrich, Cornelia M.
    Kaaks, Rudolf
    Kauczor, Hans-Ulrich
    Nattenmuller, Johanna
    BMC GASTROENTEROLOGY, 2018, 18
  • [39] Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis
    Abeysekera, Kushala W. M.
    Orr, James G.
    Gordon, Fiona H.
    Howe, Laura D.
    Hamilton-Shield, Julian
    Heron, Jon
    Hickman, Matthew
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [40] Usefulness of the SAF score to characterize NAFLD/NASH in non-cirrhotic HCV patients
    El Ray, Ahmed
    Paradis, Valerie
    Montasser, Ahmed
    Elghannam, Maged
    Shemis, Mohamed
    Nessim, Iris
    Abu-Taleb, Hoda
    Asselah, Tarik
    Mohamed, Ashiq
    Pote, Nicolas
    Akl, Maha
    Marcellin, Patrick
    EGYPTIAN LIVER JOURNAL, 2022, 12 (01)